New-onset diabetes — the pattern that is worth a second look

Type 2 diabetes is common, and it becomes more common with every decade of life. Most people who develop it in their fifties, sixties or seventies have the ordinary story: a family history, rising weight, a sedentary stretch, gradually worsening blood sugar over months or years that a routine check happens to catch. That is the overwhelming majority of new diabetes in older adults, and it is managed exactly as diabetes always is.

A smaller pattern looks different, and it is the one worth knowing about. It involves diabetes that appears suddenly rather than gradually, in someone who is not overweight and often has no family history of it at all, sometimes alongside weight that is falling rather than rising — which is the opposite of the usual type 2 picture, where weight gain typically comes first.

The explanation is mechanical. The pancreas is not only a digestive gland; the same organ makes insulin, in small clusters of cells scattered through the tissue. A tumour growing in the gland can disturb insulin production directly, and can also release substances that make the body's own insulin work less effectively, before the tumour is otherwise announcing itself in any other way. This is sometimes called type 3c diabetes when the pancreas itself is the cause, to distinguish it from ordinary type 1 or type 2.

None of this means new diabetes is a warning sign to fear. The great majority of people who develop diabetes after fifty have straightforward type 2, and it is managed by a physician in the usual way. What is worth a second look is the atypical pattern — sudden onset, no excess weight, no family history, especially with weight loss alongside it — because that combination is uncommon enough to deserve asking why. For the wider picture, see our pancreatic cancer guide.

• It appeared quickly — over weeks rather than the gradual drift typical of type 2.
• You are not overweight, and have never carried much extra weight.
• Nobody in your family has diabetes. Family history is one of the strongest predictors of ordinary type 2.
• You are losing weight, not gaining it. See unexplained weight loss and pancreatic cancer — this combination is the one worth flagging most.
• Your blood sugar is unusually hard to control despite starting treatment promptly and correctly.
• You are over fifty and this is genuinely new, not a worsening of diabetes you already had.
• There is a persistent upper abdominal or back ache alongside it.

1. 1

   A proper diabetes work-up first

   Confirming the type of diabetes matters on its own terms — it changes the treatment. Antibody testing can identify late-onset type 1. A review of medicines rules out a drug-induced cause. This step is worth doing regardless of anything else.

   In-house at CION
2. 2

   Weighing the whole picture together

   Age, weight trend, family history, how quickly the diabetes came on, how hard it is to control, and whether anything else has changed — pain, appetite, stools, jaundice. This conversation, not any single blood result, is what decides whether to look further.

   In-house at CION
3. 3

   A contrast CT scan, where it is warranted

   Where the pattern is genuinely atypical, particularly with weight loss alongside it, a contrast CT on a dedicated pancreatic protocol is the scan that looks at the gland properly. It is not offered to every new diabetic — it is offered where the story warrants it.

   In-house at CION
4. 4

   CA 19-9, read in context

   A blood marker that can be raised in pancreatic cancer, but also by several benign conditions, and it is not a screening test on its own. Where it is used, it is one part of a bigger picture rather than a yes-or-no answer.

   In-house at CION
5. 5

   Endoscopic ultrasound, where a finding needs confirming

   If imaging identifies something that needs a tissue diagnosis, an endoscopic ultrasound with biopsy is the standard next step, giving the closest available view of the gland.

   Coordinated with specialist endoscopy partners

Where diabetes and pancreatic disease do coexist, they are managed together rather than by two separate teams working past each other. Blood sugar control affects how well someone tolerates treatment, and treatment can in turn affect blood sugar — so the two are reviewed at the same appointments, not on separate tracks.

If pancreatic surgery is part of the treatment plan, it is worth knowing that removing part or all of the pancreas can change insulin production and may require insulin afterwards, sometimes called type 3c diabetes. This is discussed honestly before any operation, and it is coordinated with our specialist HPB surgery partners alongside the medical oncology team who manage the diabetes itself.

Medical disclaimer: This page explains the difference between ordinary new-onset diabetes and the atypical pattern associated with pancreatic disease, and is reviewed by a CION medical oncologist with reference to NCCN guidance for pancreatic adenocarcinoma. It is general information, not a diagnosis. Most new diabetes after the age of fifty is ordinary type 2 diabetes and does not indicate pancreatic disease. Blood tests, CA 19-9, pancreatic-protocol CT, MRI/MRCP, medical oncology, radiation oncology, nutrition and pancreatic-enzyme support and supportive care are delivered by CION; endoscopic ultrasound and biopsy, ERCP, biliary and duodenal stenting, coeliac plexus block and all pancreatic surgery are coordinated with specialist HPB, gastroenterology and endoscopy partner centres and may be billed there.